PATENT CLAIM ANALYSIS

Application Number: 15874485
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "252040"]

Abstract:
Compounds and compositions are presented that inhibit K-Ras, and especially mutant K-Ras. Certain compounds preferentially or even selectively inhibit specific forms of mutant K-Ras, and particularly the G12D mutant form.

Claim (Index 24):
The method of  claim 23 , wherein the neoplastic disease comprises a mutant K-Ras with a, mutation at glycine-12 (Gly12), Gly13, and/or glutamine-61 (Gln61).

Metadata:
- Claim Count in Document: 22.0
- Percentile: 86.0
- Lexical Diversity: 1.36
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15563813', '15093951', '15805716', '15566648', '14511425']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7897241617718289
- 35 USC 102 Novelty (BERT): 0.533398227144339
- Combined Prediction Score: 0.76409156830908
- Mean Citation Score: 304.510234
- Max Citation Score: 360.2005
- Similarity Product: 242.65145943412185

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test